Clobazam

Product NDC
67877-664
11-digit product format
678770664
Labeler code
67877
Product ID
67877-664_f9dc8ac4-86be-49ab-9c2c-c60658f49d8f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Clobazam
Dosage form
TABLET
Route
ORAL
Labeler
Ascend Laboratories, LLC
Application
ANDA212714
Marketing category
ANDA
Marketing start
2023-10-18
Substance
CLOBAZAM
Active strength
5 mg/1
Pharmacologic classes
Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
2MRO291B4UCLOBAZAM22316-47-8CLOBAZAM

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
67877-664-01678770664011 BOTTLE in 1 CARTON (67877-664-01) / 100 TABLET in 1 BOTTLE1 bottle2023-10-18NoNoHistorical
67877-664-0567877066405500 TABLET in 1 BOTTLE (67877-664-05) 500 tablet2023-10-18NoNoHistorical
67877-664-33678770664331 BLISTER PACK in 1 CARTON (67877-664-33) / 10 TABLET in 1 BLISTER PACK1 blister pack2023-10-18NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
ClobazamAscend Laboratories, LLC | Alkem Laboratories Limited2025-06-10Human Prescription Drug Label18